8 citations
,
July 2022 in “Chinese Journal of Integrative Medicine” This review discusses the molecular phylogeny, chemical constituents, and therapeutic applications of medicinal plants in the Ranunculales order and reports no new clinical results.
2 citations
,
October 2025 in “Frontiers in Medicine” This study identified several previously unrecognized adverse events linked to ISO, including serious conditions such as Dandy-Walker syndrome and suicidal ideation, suggesting that safety measures and drug labeling should be updated.
2 citations
,
January 2020 in “Tropical Journal of Pharmaceutical Research” This review discusses the extensive variety of traditional Chinese medicine preparations used for treating hair loss, primarily consisting of botanical materials, but reports no new clinical results.
August 2025 in “Journal of the Korean Society of Cosmetology” This study examined 201 Korean academic articles on scalp and hair research from 1994 to 2024, finding a shift from technique-driven studies to more interdisciplinary, application-oriented research, reflecting broader industrial, medical, and psychological interests over time.
This study found that non-bleeding adverse events associated with NOACs affect multiple organ systems, emphasizing the importance of clinical vigilance. Specific NOACs like dabigatran, apixaban, edoxaban, and rivaroxaban were linked to distinct adverse reactions, including metabolic imbalances, thyroid disorders, and menstrual irregularities.